B. Riley Raises Celsius (NASDAQ:CELH) Price Target to $52.00

Key Points

• B. Riley has raised the price target for Celsius (NASDAQ:CELH) from $49.00 to $52.00, indicating a potential upside of 9.59% from the stock's previous close.
• Multiple analysts have issued positive ratings for Celsius, with four assigning a buy rating and the consensus rating classified as a "Moderate Buy."
• Despite this bullish sentiment, Celsius reported a drop in year-over-year revenue and reported earnings of $0.18 per share, which was below analysts' expectations of $0.20.

Celsius (NASDAQ:CELH - Get Free Report) had its target price boosted by stock analysts at B. Riley from $49.00 to $52.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. B. Riley's price objective points to a potential upside of 9.59% from the stock's previous close.

CELH has been the subject of a number of other reports. JPMorgan Chase & Co. lifted their target price on shares of Celsius from $39.00 to $44.00 and gave the company an "overweight" rating in a research note on Friday, May 2nd. Wall Street Zen upgraded shares of Celsius from a "sell" rating to a "hold" rating in a research note on Sunday, July 13th. Roth Capital reiterated a "buy" rating and issued a $52.00 target price (up from $46.00) on shares of Celsius in a research note on Thursday, June 26th. Piper Sandler lifted their target price on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a research note on Wednesday, June 4th. Finally, UBS Group boosted their price objective on shares of Celsius from $49.00 to $57.00 and gave the stock a "buy" rating in a research note on Thursday, July 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Celsius presently has a consensus rating of "Moderate Buy" and an average price target of $47.28.

Celsius Stock Up 1.0%

Celsius stock traded up $0.49 during trading hours on Tuesday, hitting $47.45. 3,287,097 shares of the company traded hands, compared to its average volume of 8,222,141. The firm's 50-day simple moving average is $42.75 and its two-hundred day simple moving average is $34.97. The firm has a market cap of $12.23 billion, a P/E ratio of 147.78, a P/E/G ratio of 1.65 and a beta of 1.45. Celsius has a 1-year low of $21.10 and a 1-year high of $48.47.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). The firm had revenue of $329.28 million during the quarter, compared to analysts' expectations of $349.09 million. Celsius had a return on equity of 42.12% and a net margin of 8.40%. The business's revenue was down 7.4% on a year-over-year basis. During the same period last year, the business earned $0.27 earnings per share. On average, equities research analysts predict that Celsius will post 0.89 earnings per share for the current year.

Insider Transactions at Celsius

In other news, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the completion of the sale, the insider directly owned 18,017,770 shares of the company's stock, valued at $851,699,987.90. This represents a 1.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO John Fieldly sold 132,171 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $43.06, for a total value of $5,691,283.26. Following the completion of the sale, the chief executive officer directly owned 1,169,380 shares of the company's stock, valued at approximately $50,353,502.80. This trade represents a 10.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 562,974 shares of company stock worth $25,758,418. Corporate insiders own 2.20% of the company's stock.

Institutional Trading of Celsius

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Bridges Investment Management Inc. increased its stake in shares of Celsius by 13.3% in the 2nd quarter. Bridges Investment Management Inc. now owns 49,774 shares of the company's stock valued at $2,309,000 after acquiring an additional 5,825 shares during the last quarter. New York State Teachers Retirement System grew its stake in shares of Celsius by 2.1% in the second quarter. New York State Teachers Retirement System now owns 156,973 shares of the company's stock valued at $7,282,000 after buying an additional 3,240 shares in the last quarter. Bayforest Capital Ltd grew its position in shares of Celsius by 17.9% in the 2nd quarter. Bayforest Capital Ltd now owns 21,429 shares of the company's stock valued at $994,000 after acquiring an additional 3,255 shares during the period. RFG Advisory LLC bought a new position in shares of Celsius in the 2nd quarter valued at about $1,395,000. Finally, Moran Wealth Management LLC grew its position in shares of Celsius by 108.0% in the 2nd quarter. Moran Wealth Management LLC now owns 171,268 shares of the company's stock valued at $7,945,000 after acquiring an additional 88,941 shares during the period. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.